LON:OBD Oxford BioDynamics (OBD) Share Price, News & Analysis GBX 1.20 -0.05 (-4.23%) (As of 12/20/2024 12:06 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades About Oxford BioDynamics Stock (LON:OBD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Oxford BioDynamics alerts:Sign Up Key Stats Today's Range 1.15▼ 1.4050-Day Range 0.98▼ 2.2052-Week Range 0.76▼ 36.90Volume5.33 million shsAverage Volume1.89 million shsMarket Capitalization£3.74 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewOxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.Read More… Receive OBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oxford BioDynamics and its competitors with MarketBeat's FREE daily newsletter. Email Address OBD Stock News HeadlinesOxford BioDynamics Secures Loan to Extend Financial RunwayDecember 20 at 3:20 PM | markets.businessinsider.comOxford BioDynamics explores funding amid share fluctuationDecember 6, 2024 | uk.investing.comThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… December 22, 2024 | Crypto 101 Media (Ad)Oxford BioDynamics Issues Shares to Preserve CashOctober 29, 2024 | markets.businessinsider.comOxford BioDynamics Unveils Promising COVID Severity TestOctober 25, 2024 | markets.businessinsider.comLONDON MARKET CLOSE: Stocks climb as PM says UK is open for businessOctober 14, 2024 | lse.co.ukOxford BioDynamics pledges to cut costs amid need to raise extra fundsOctober 14, 2024 | lse.co.ukNew Oxford trucking company pleads to Clean Air Act violation - disabled emissions monitorSeptember 27, 2024 | yahoo.comSee More Headlines OBD Stock Analysis - Frequently Asked Questions How have OBD shares performed this year? Oxford BioDynamics' stock was trading at GBX 28 at the beginning of 2024. Since then, OBD stock has decreased by 95.7% and is now trading at GBX 1.20. View the best growth stocks for 2024 here. How were Oxford BioDynamics' earnings last quarter? Oxford BioDynamics Plc (LON:OBD) released its quarterly earnings data on Tuesday, June, 16th. The biotechnology company reported ($2.20) earnings per share (EPS) for the quarter. How do I buy shares of Oxford BioDynamics? Shares of OBD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Oxford BioDynamics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Oxford BioDynamics investors own include 4D pharma (DDDD), B&M European Value Retail (BME), BP (BP), Coats Group (COA), genedrive (GDR), Greencore Group (GNC) and Intel (INTC). Company Calendar Last Earnings6/16/2020Today12/22/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:OBD CUSIPN/A CIKN/A Webwww.oxfordbiodynamics.com Phone+44-1865-518910FaxN/AEmployees45Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-11,110,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-266.70% Return on Assets-56.23% Debt Debt-to-Equity Ratio370.22 Current Ratio0.68 Quick Ratio2.80 Sales & Book Value Annual Sales£176,000.00 Price / Sales21.26 Cash FlowGBX 0.30 per share Price / Cash Flow3.98 Book ValueGBX 1 per share Price / Book1.20Miscellaneous Outstanding Shares311,860,000Free FloatN/AMarket Cap£3.74 million OptionableNot Optionable Beta0.42 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (LON:OBD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford BioDynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford BioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.